Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.1920
-0.0089 (-4.43%)
At close: Jun 9, 2026
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of $318.42 million as of June 9, 2026. Its market cap has decreased by -22.63% in one year.
Market Cap
318.42M
Enterprise Value
393.12M
Revenue
1.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
Market Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 318.42M, an increase of 2,994.72%. That is a compound annual growth rate of 15.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 333.18M | -7.03% |
| Dec 31, 2025 | 358.39M | -1.53% |
| Dec 31, 2024 | 363.95M | -55.71% |
| Dec 29, 2023 | 821.84M | -1.00% |
| Dec 30, 2022 | 830.10M | 25.14% |
| Dec 31, 2021 | 663.34M | -47.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 401.44M |
| Glorywin Entertainment Group | 343.05M |
| Silence Therapeutics | 291.44M |
| Vaxart | 150.02M |
| HST Global | 99.00M |
| Sangamo Therapeutics | 89.07M |
| BioStem Technologies | 69.06M |
| NDT Pharmaceuticals | 57.16M |